Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...

Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...

Please provide your email address to receive an email when new articles are posted on . A retrospective analysis showed pathological complete response was achieved by more than half of patients.

BioNTech SE (NASDAQ:BNTX) shares rose 6.4% in pre-market trading on Monday after the company reported updated survival data from stage 1 of the Phase 3 PRESERVE-003 trial evaluating gotistobart in ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...

Patients on an experimental drug called gotistobart lived a median of 18.5 months after starting treatment for advanced squamous non-small cell lung cancer, compared with 10.0 months for patients ...

Data from the PRESERVE-003 trial may support the use of a novel chemotherapy-free option for patients with squamous non–small cell lung cancer. Treatment with gotistobart meaningfully improved overall ...

BioNTech SE (Nasdaq: BNTX) and OncoC4, Inc. presented updated clinical trial data showing that their investigational drug gotistobart nearly doubled median overall survival compared with ...

Gotistobart continues to show potential as chemotherapy-free monotherapy to reignite anti-tumor immunity in previously treated patients with squamous non-small cell lung cancer, where median survival ...

Ivonescimab's landmark overall survival win against PD-1 in their chemotherapy combinations in first-line lung cancer drew both hope and criticism at ASCO 2026. (Angus Liu/Fierce Pharma) It’s the ...